EDITOR |
|
|
 |
Neil Love, MD
Medical Oncologist
Editor, Colorectal Cancer Update
for Nurses
Research To Practice
Miami, Florida |
|
|
| |
|
|
|
FACULTY AFFILIATIONS |
|
|
 |
Alan P Venook, MD
Professor of Clinical Medicine
University of California
San Francisco
San Francisco, California
|
 |
Tom Weber, ANP-BC
Adult Nurse Practitioner
GI Medical Oncology
UCSF Comprehensive
Cancer Center
San Francisco, California |
CONTENT VALIDATION AND DISCLOSURES
Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and
state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers
of CNE activities. Real or apparent conflicts of interest are identified and resolved through a conflict of
interest resolution process. In addition, all activity content is reviewed by both a member of the RTP
scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies
referenced and patient care recommendations.
FACULTY — Mr Weber had no real or apparent conflicts of interest to disclose. The following faculty
(and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved
through a conflict of interest resolution process: Dr Venook — Advisory Committee: Amgen Inc, ImClone
Systems Incorporated; Grant Funding: Genentech BioOncology; Paid Research: Bayer Pharmaceuticals
Corporation, Novartis Pharmaceuticals Corporation, Onyx Pharmaceuticals Inc, Pfizer Inc.
EDITOR — Neil Love: Dr Love is president and CEO of Research To Practice, which receives funds
in the form of educational grants to develop CME/CNE activities from the following commercial
interests: Abraxis BioScience, AstraZeneca Pharmaceuticals LP, Aureon Laboratories Inc, Bayer
Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Biogen Idec, Bristol-Myers Squibb Company,
Celgene Corporation, Eisai Inc, Eli Lilly and Company, Genentech BioOncology, Genomic Health Inc,
GlaxoSmithKline, ImClone Systems Incorporated, Merck and Company Inc, Millennium Pharmaceuticals
Inc, Novartis Pharmaceuticals Corporation, Ortho Biotech Products LP, OSI Oncology, Pfizer Inc, Roche
Laboratories Inc, Sanofi-Aventis, Synta Pharmaceuticals Corp and Wyeth.
RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers
for Research To Practice have no real or apparent conflicts of interest to disclose.
This educational activity contains discussion of published and/or investigational uses of agents that are not
indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any
agent outside of the labeled indications. Please refer to the official prescribing information for each product
for discussion of approved indications, contraindications and warnings. The opinions expressed are those
of the presenters and are not to be construed as those of the publisher or grantors.
